Microscope

Intracellular Infections

An advanced analysis of blood cells on the presence and activity of hidden pathogens

Intracellular Infections

Biocoherence collaborates with an advanced laboratory that has developed a new combined analytical approach: The in situ use of fluorescently labeled DNA probes and morphometry in blood cells. This approach has been patented and has proven to work very well in practice. What is unique is that, in addition to the presence of the pathogen, the metabolic activity in the cells is also displayed. When the activity is 0% it means that the pathogen is not active, at 100% the pathogen is very active.

CELL WALL DEFICIENT BACTERIA (CWBD) – INVISIBLE TO THE IMMUNE SYSTEM

Chronic infections that last for a long time

Bacteria, fungi and viruses can cause a variety of inflammatory responses characterized by traditional inflammatory parameters such as fever, redness, pain, swelling, fatigue and loss of function. For years, the idea existed that these pathogens are treated with antibiotics, among other things, and that the infections can be suppressed with this.

In addition to the known infections, however, many pathogens are also capable of causing chronic intracellular infections. The medical literature shows that chronic syndromes, but especially the resulting “post-infectious syndromes” are of much greater importance than originally assumed in view of their impact on quality of life. These intracellular infections may become apparent months or later so that they are not associated with the earlier original infection. These late reactions to a previous infection are thought to be responsible for a considerable number of diseases, which therefore have a strong autoimmune aspect.

rota virus

THE STANDARD DIAGNOSTICS AND INTERVENTION IS NOT SUFFICIENT

An analysis that exceeds standard PCR

Besides the fact that CWDBs do not cause classic symptoms (and thus are not visible to a medical practitioner), they are also difficult to diagnose using traditional methods such as:

The classic breeding method. Intracellular bacteria are difficult to culture and form very small colonies that are often difficult to distinguish
Serological methods: Demonstrating anti-CWDB antigens in plasma is pointless. After all, the immune system does not recognize this form. In addition, most immunoglobulins target antigens located in/on the bacterial cell wall. A CWBD has no cell wall and is therefore low immunogenic and virtually insensitive to this detection method.
PCR: CWDB specific DNA has been demonstrated in recent years with PCR of patient material. The disadvantage here is that the intracellular and extracellular distinction has disappeared. In addition, this material contains a very large number of inhibitors that negatively affect PCR sensitivity. The result is a test result with a 30-40% false negative result. PCR should then always be used in combination with other analytical methods.

USE TARGETED INTERVENTIONS

Presence and activity of the pathogen

This analysis not only makes it possible to take an important diagnostic step, but also opens the possibility to objectively monitor the effect of an intervention aimed at the elimination of intracellular pathogens, both in terms of the extent of the infection as the activity of the pathogen.

The analysis is offered to therapists who are active in complementary care. They can (with the support of Biocoherence Netherlands) translate the results into an intervention strategy. This strategy is based on a scientific interpretation of the type of interleukins and other biomarkers towards a nutritional and supplement approach that can suppress these substances or prevent their formation.

A therapist will receive an extensive report and you will be trained by us in the interpretation.

Easily order the Intracellular Infection Analysis

The Intracellular Infection Analysis can be ordered by therapists who, when registered with us, can order this analysis via our webshop. We take care of the contact with the lab, the client can have blood drawn via an injection clinic in his environment. The report is provided by us and prepared in the My Health platform or made available separately.